AstraZeneca’s novel antibiotic candidate AZD0914 given Fast Track status by US FDA
3 June 2014 | By AstraZeneca
AstraZeneca announced that the US Food and Drug Administration has designated its novel investigational drug AZD0914 as a Qualified Infectious Disease Product...